Kolexia
Rougier Philippe Gastro-entérologie
Rougier Philippe
Gastro-entérologie
Hôpital Européen Georges Pompidou
Paris, France
162 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Adénocarcinome Tumeurs de l'estomac Tumeurs du foie Tumeurs du côlon Carcinomes Tumeurs du pancréas Tumeurs du rectum

Collaborateurs

Voir plus
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Ducreux Michel
Ducreux Michel
Gustave-Roussy, Villejuif, France
Mitry Jean-Emmanuel
Mitry Jean-Emmanuel
Centre Paoli-Calmettes, Marseille, France
Lepere Celine
Lepere Celine
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
Servier
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
GASTFOX: ESSAI DE PHASE III RANDOMISE EVALUANT LE FOLFOX AVEC OU SANS DOCETAXEL (TFOX) EN 1ère LIGNE DE CHIMIOTHERAPIE DES ADENOCARCINOMES OESO-GASTRIQUES LOCALEMENT AVANCES OU METASTATIQUES
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   11 juillet 2023
Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery: Front-line Combination Therapy of Sunitinib Malate Plus Chemotherapy With Leucovorin/5-Fluorouracil and Irinotecan (FOLFIRI) for Rectal Cancer Patients With Synchronous Non-Resectable Metastases: A Phase II Non Controlled Study. (SUREMETS)
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   26 août 2022
Erratum to: Chemoembolization of Neuroendocrine Liver Metastases Using Streptozocin and Tris-acryl Microspheres: Embozar (EMBOsphere + ZAnosaR) Study.
Cardiovascular and interventional radiology   20 novembre 2019
RAINBOW: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Essai Clinique (Lilly)   06 septembre 2019
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
European journal of cancer (Oxford, England : 1990)   26 mai 2018
A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group.
Annals of oncology : official journal of the European Society for Medical Oncology   02 mars 2018
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   01 mars 2018
Hepatic arterial infusion in the management of colorectal cancer liver metastasis: Current and future perspectives.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 décembre 2017
PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report.
Cancers   26 mai 2017